BNP Paribas Financial Markets’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $269M | Sell |
|
|||||
|
2025
Q2 | $275M | Sell |
|
|||||
|
2025
Q1 | $474M | Buy |
|
|||||
|
2024
Q4 | $384M | Buy |
|
|||||
|
2024
Q3 | $311M | Buy |
|
|||||
|
2024
Q2 | $259M | Buy |
|
|||||
|
2024
Q1 | $231M | Buy |
|
|||||
|
2023
Q4 | $189M | Buy |
|
|||||
|
2023
Q3 | $152M | Buy |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $90.4M | Buy |
|
|||||
|
2022
Q4 | $72.4M | Buy |
|
|||||
|
2022
Q3 | $58.6M | Sell |
|
|||||
|
2022
Q2 | $54.5M | Buy |
|
|||||
|
2022
Q1 | $46.7M | Sell |
|
|||||
|
2021
Q4 | $52.7M | Buy |
|
|||||
|
2021
Q3 | $29.8M | Sell |
|
|||||
|
2021
Q2 | $45M | Buy |
|
|||||
|
2021
Q1 | $35M | Sell |
|
|||||
|
2020
Q4 | $38.2M | Sell |
|
|||||
|
2020
Q3 | $74.1M | Buy |
|
|||||
|
2020
Q2 | $43.9M | Sell |
|
|||||
|
2020
Q1 | $36.9M | Buy |
|
|||||
|
2019
Q4 | $16.4M | Sell |
|
|||||
|
2019
Q3 | $41.1M | Sell |
|
|||||
|
2019
Q2 | $57.7M | Buy |
|
|||||
|
2019
Q1 | $20.8M | Sell |
|
|||||
|
2018
Q4 | $94.5M | Sell |
|
|||||
|
2018
Q3 | $133M | Sell |
|
|||||
|
2018
Q2 | $118M | Sell |
|
|||||
|
2018
Q1 | $120M | Sell |
|
|||||
|
2017
Q4 | $186M | Buy |
|
|||||
|
2017
Q3 | $213M | Buy |
|
|||||
|
2017
Q2 | $209M | Sell |
|
|||||
|
2017
Q1 | $207M | Buy |
|
|||||
|
2016
Q4 | $24.8M | Sell |
|
|||||
|
2016
Q3 | $27.6M | Buy |
|
|||||
|
2016
Q2 | $14.4M | Sell |
|
|||||
|
2016
Q1 | $26.2M | Buy |
|
|||||
|
2015
Q4 | $31.6M | Buy |
|
|||||
|
2015
Q3 | $16.5M | Sell |
|
|||||
|
2015
Q2 | $23.3M | Sell |
|
|||||
|
2015
Q1 | $43.2M | Buy |
|
|||||
|
2014
Q4 | $35.1M | Sell |
|
|||||
|
2014
Q3 | $32.1M | Buy |
|
|||||
|
2014
Q2 | $15.9M | Sell |
|
|||||
|
2014
Q1 | $29M | Sell |
|
|||||
|
2013
Q4 | $44.4M | Buy |
|
|||||
|
2013
Q3 | $48.7M | Buy |
|
|||||
|
2013
Q2 | $15M | Buy |
|